AUD/JPY gains ground to near 111.00 as BoJ signals prolonged rate hold
The AUD/JPY cross attracts some buyers to around 110.90 during the early European session on Friday. The Japanese Yen (JPY) softens against the Australian Dollar (AUD) amid uncertainty surrounding the Bank of Japan's (BoJ) interest rate path. Traders brace for the release of Japan’s Gross Domestic Product (GDP) report for the fourth quarter (Q4), which will be released next week.
BoJ Governor Kazuo Ueda indicated a likely "prolonged hold" on interest rates due to economic uncertainty from the Middle East war, despite a long-term commitment to rate normalization. Meanwhile, Japan’s Finance Minister Satsuki Katayama said on Friday that the government is ready to take steps in a timely fashion to combat the economic impact from the Iran conflict. She added that Japan is not fully exited from deflation.
Traders have priced in nearly a 5% chance that the Japanese central bank will move up borrowing costs from 0.75% this month. The probability rises to about 65% if the April meeting is included, according to Bloomberg.
On the Aussie front, a narrower-than-expected Trade Surplus might cap the upside for the AUD in the near term. Australia’s Trade Surplus shrank to 2,631M MoM in January, the Australian Bureau of Statistics showed on Thursday. This figure came in below the market consensus of 3,900M and followed December’s surplus of 3,373M.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic files for IPO: lost $4.2 billion last year, revenue grew 12x to $4.6 billion, risk section warns of "threats to human survival"
Anthropic's IPO prospectus reveals that its spending on computing power and infrastructure will reach $7.33 billion in 2025, a twofold increase from 2024, accounting for more than half of its total operating expenses of $12.65 billion. The company plans to continue investing over $500 billion in the future. The risk section of the prospectus extends to 80 pages, explicitly warning that its AI models could pose "catastrophic or even existential threats," and may even resist shutdowns or manipulate information.
Meta shocks Wall Street by hiring MongoDB CEO and makes a high-profile entry into enterprise AI business
Meta has established an enterprise AI division called "Meta Enterprise Platform," which Mark Zuckerberg described as "the next important pillar." MongoDB CEO CJ Desai has been recruited to lead it. Analysts noted that Zuckerberg specifically poached a CEO from a publicly listed company to demonstrate the importance of this move. Desai's departure was announced just one day before Investor Day, with the timing surprising the public.
RBA set to hike interest rate to 4.60% in September as inflation remains elevated
AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose
This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.
